A detailed history of Eversept Partners, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eversept Partners, LP holds 4,720,460 shares of TEVA stock, worth $87 Million. This represents 5.79% of its overall portfolio holdings.

Number of Shares
4,720,460
Previous 6,025,169 21.65%
Holding current value
$87 Million
Previous $85 Million 9.77%
% of portfolio
5.79%
Previous 6.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $16.7 Million - $22.7 Million
-1,304,709 Reduced 21.65%
4,720,460 $76.7 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $1.38 Million - $1.86 Million
-129,185 Reduced 2.1%
6,025,169 $85 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $6.48 Million - $8.48 Million
-797,731 Reduced 11.47%
6,154,354 $64.3 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $5.36 Million - $7.66 Million
-715,959 Reduced 9.34%
6,952,085 $70.9 Million
Q2 2023

Nov 08, 2023

BUY
$7.2 - $9.47 $10.6 Million - $14 Million
1,473,472 Added 23.79%
7,668,044 $57.7 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $10.6 Million - $14 Million
1,473,472 Added 23.79%
7,668,044 $57.7 Million
Q1 2023

Nov 08, 2023

BUY
$8.36 - $11.37 $12.4 Million - $16.9 Million
1,481,975 Added 31.45%
6,194,572 $54.8 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $12.4 Million - $16.9 Million
1,481,975 Added 31.45%
6,194,572 $54.8 Million
Q4 2022

Nov 08, 2023

BUY
$7.95 - $9.48 $5.16 Million - $6.16 Million
649,662 Added 15.99%
4,712,597 $43 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $5.16 Million - $6.16 Million
649,662 Added 15.99%
4,712,597 $43 Million
Q3 2022

Nov 08, 2023

SELL
$6.86 - $11.95 $3.07 Million - $5.35 Million
-447,767 Reduced 9.93%
4,062,935 $32.8 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $3.07 Million - $5.35 Million
-447,767 Reduced 9.93%
4,062,935 $32.8 Million
Q2 2022

Nov 08, 2023

BUY
$7.38 - $10.4 $2.71 Million - $3.82 Million
367,100 Added 8.86%
4,510,702 $33.9 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $2.71 Million - $3.82 Million
367,100 Added 8.86%
4,510,702 $33.9 Million
Q1 2022

Nov 08, 2023

SELL
$7.33 - $9.39 $25.8 Million - $33.1 Million
-3,524,442 Reduced 45.96%
4,143,602 $38.9 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $13.5 Million - $17.3 Million
1,842,104 Added 80.04%
4,143,602 $38.9 Million
Q4 2021

Nov 08, 2023

SELL
$7.9 - $10.19 $9.9 Million - $12.8 Million
-1,253,306 Reduced 35.26%
2,301,498 $18.4 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $9.9 Million - $12.8 Million
-1,253,306 Reduced 35.26%
2,301,498 $18.4 Million
Q3 2021

Nov 08, 2023

SELL
$8.38 - $10.18 $2.09 Million - $2.54 Million
-249,601 Reduced 6.56%
3,554,804 $34.6 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $2.09 Million - $2.54 Million
-249,601 Reduced 6.56%
3,554,804 $34.6 Million
Q2 2021

Nov 08, 2023

SELL
$9.9 - $11.56 $5.45 Million - $6.36 Million
-550,351 Reduced 12.64%
3,804,405 $37.7 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $5.45 Million - $6.36 Million
-550,351 Reduced 12.64%
3,804,405 $37.7 Million
Q1 2021

Nov 08, 2023

BUY
$10.34 - $12.81 $16.6 Million - $20.6 Million
1,606,506 Added 58.46%
4,354,756 $50.3 Million
Q1 2021

May 13, 2021

BUY
$10.34 - $12.81 $16.6 Million - $20.6 Million
1,606,506 Added 58.46%
4,354,756 $50.3 Million
Q4 2020

Nov 08, 2023

SELL
$8.61 - $11.04 $42.4 Million - $54.3 Million
-4,919,794 Reduced 64.16%
2,748,250 $26.5 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $3.05 Million - $3.91 Million
353,895 Added 14.78%
2,748,250 $26.5 Million
Q3 2020

Nov 08, 2023

SELL
$8.57 - $12.69 $45.2 Million - $66.9 Million
-5,273,689 Reduced 68.77%
2,394,355 $21.6 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $20.5 Million - $30.4 Million
2,394,355 New
2,394,355 $21.6 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.